Trial intelligence / Profile preview

Pre-eclampsia Intervention 3 Trial

PACTR202104532026017Phase 3Recruiting

Sponsor
Stellenbosch University
Start
Jan 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in preeclampsia comparing Metformin SR with Placebo (2 arms). Primary endpoint: Prolongation of gestation. Started Jan 2022; status: recruiting.

02

Drugs

metformin
03

Conditions

preeclampsia

Beyond the preview

Go deeper on PACTR202104532026017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202104532026017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call